SYK and neoplasm: Apart from the original purpose of fostamatinib, inhibiting SYK to treat immune thrombocytopenia disease, there was one current study that has proven that SYK suppression by fostamatinib impacted tumor-associated macrophages behavior and improved the sensitize PC to gemcitabine 70.